1st Quarter - Termination

FAEGRE BAKER DANIELS CONSULTING for USAGAINST ALZHEIMER'S

Firm
Client
Income
$10,000
Expenses
—
Terminated
Jan 31, 2020

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 1126 - Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019; H.R. 2283 - CHANGE Act of 2019

LobbyistCovered position, as disclosed
NICK MANETTO Legislative Assistant, Rep. Christopher H. Smith (R-NJ)

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2283 (116th), S. 1126 (116th)

Budget/Appropriations BUD

Fiscal Year 2021 funding for Alzheimer's disease research and policies to enhance NIH Alzheimer's research.

LobbyistCovered position, as disclosed
NICK MANETTO Legislative Assistant, Rep. Christopher H. Smith (R-NJ)

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.